SGL5213

Overview

SGL5213 is a potent, oral active and low-absorbable sodium-dependent glucose cotransporter 1 ( SGLT1 ) inhibitor, with IC 50 values of 29 nM and 20 nM for hSGLT1 and hSGLT2, respectively. SGL5213 has potential to treat type 2 diabetes treatment.

Application

Products | Products > Disease Areas > Metabolic or Endocrine Disease | Products > Signaling Pathways > Membrane Transporter/Ion Channel | Products > Research Areas > Metabolic Disease | Products > Signaling Pathways > SGLT

Product Information

• Catalog No.: HY-114308
• CAS No.: 1240305-17-2
• Molecular Formula: C37H55N3O8
• Molecular Weight: 669.85
• Purity: 99.98%
• Storage: Please store the product under the recommended conditions in the Certificate of Analysis.

Source

Original product source